#USA #Portland #Araceli Biosciences #Christine Tsingos #Bio-Rad Laboratories

Christine Tsingos Joins the Board of Araceli Biosciences

Araceli Biosciences, a leader in accelerating drug discovery through high-throughput imaging solutions, announced the appointment of Christine A. Tsingos to its Board of Directors. This hiring marks a significant step for the company as it embarks on its next phase of growth.

A Seasoned Executive

Christine Tsingos brings over 30 years of experience in various high-ranking roles, primarily in finance and corporate governance. She has a proven track record that includes strategic financial planning, capital allocation, investor relations, mergers and acquisitions, as well as information technology. Her past experience as Executive Vice President and Chief Financial Officer at Bio-Rad Laboratories from 2002 to 2019 adds tremendous value to her role at Araceli.

Bill Cortelyou, the Chair of Araceli Biosciences’ Board of Directors, expressed confidence in Tsingos' capabilities, stating that her extensive background in life sciences and long-term value creation will bolster the board as the company pursues disciplined growth. Tsingos’ strategic insights will be particularly beneficial during this pivotal time for the organization.

Focus on Drug Discovery

Tsingos' appointment comes at a time when Araceli aims to revolutionize laboratory environments by integrating artificial intelligence into drug discovery. CEO Matt Beaudet commented that her experience in transitioning companies from offering standalone tools to developing integrated systems will be crucial as Araceli grows. Under her guidance, the company hopes to solidify its foundations for sustainable, large-scale growth.

A Record of Achievement

Throughout her career, Tsingos has not only overseen financial operations at Bio-Rad but has also been instrumental in guiding the company's strategic expansion. She has been involved in various boards, including Envista Holdings and Varex Imaging Corporation, and previously served on the boards of Onto Innovation and Telesis Bio. Her academic credentials include a Bachelor’s degree in International Studies from the American University and an MBA in International Business from George Washington University. Notably, she was recognized as the CFO of the Year by the San Francisco Business Times in 2010.

A Vision for the Future

In her new role, Tsingos identified the robust momentum that Araceli has cultivated in a relatively short period. She emphasized the importance of establishing necessary foundations to support expansive growth and expressed enthusiasm at being part of this transformative journey for the company.

As Araceli Biosciences continues to advance biological discovery through its innovative high-throughput imaging capabilities, Tsingos’ appointment represents a strategic move toward ensuring the longevity and influence of the company's contributions to the healthcare sector.

About Araceli Biosciences

Araceli Biosciences specializes in facilitating biological discovery through state-of-the-art imaging solutions that aid researchers in generating richer data and speeding up decision-making processes in drug discovery and life sciences research workflows.

For media inquiries, contact:
Don Weldon, Vice President of Marketing
Email: [email protected]